Longitudinal Investigation of Pubertal Milestones and Hormones as a Function of Body Fat in Girls.
adolescent
body fat
neuroendocrine
obesity
puberty
Journal
The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362
Informations de publication
Date de publication:
13 May 2021
13 May 2021
Historique:
received:
16
12
2020
pubmed:
26
2
2021
medline:
3
11
2021
entrez:
25
2
2021
Statut:
ppublish
Résumé
Epidemiologic studies have demonstrated that overweight/obese girls (OW/OB) undergo thelarche and menarche earlier than normal weight girls (NW). There have been no longitudinal studies to specifically investigate how body weight/fat affects both clinical and biochemical pubertal markers in girls. To investigate the effect of total body fat on reproductive hormones and on the maturation of estrogen-sensitive tissues during puberty in girls. Ninety girls (36 OW/OB, 54 NW), aged 8.2 to 14.7 years, completed 2.8 ± 1.7 study visits over 4 years. Visits included dual-energy x-ray absorptiometry to calculate total body fat (TBF), Tanner staging, breast ultrasound for morphological staging (BMORPH; A-E), pelvic ultrasound, hormone tests, and assessment of menarchal status. The effect of TBF on pubertal markers was determined using a mixed, multistate, or Cox proportional hazards model, controlling for baseline BMORPH. NW were older than OW/OB (11.3 vs 10.2 years, P < .01) at baseline and had more advanced BMORPH (P < .01). Luteinizing hormone, estradiol, and ovarian and uterine volumes increased with time with no effect of TBF. There was a time × TBF interaction for follicle-stimulating hormone, inhibin B, estrone, total and free testosterone, and androstenedione: Levels were initially similar, but after 1 year, levels increased in girls with higher TBF, plateaued in girls with midrange TBF, and decreased in girls with lower TBF. Girls with higher TBF progressed through BMORPH stage D more slowly but achieved menarche earlier than girls with lower TBF. In late puberty, girls with higher TBF demonstrate differences in standard hormonal and clinical markers of puberty. Investigation of the underlying causes and clinical consequences of these differences in girls with higher TBF deserves further study.
Identifiants
pubmed: 33630047
pii: 6145760
doi: 10.1210/clinem/dgab092
pmc: PMC8118584
doi:
Banques de données
ClinicalTrials.gov
['NCT02583646']
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1668-1683Informations de copyright
Published by Oxford University Press on behalf of the Endocrine Society 2021.
Références
Breast Cancer Res. 2017 Nov 29;19(1):128
pubmed: 29187227
Eur J Endocrinol. 2010 Dec;163(6):895-900
pubmed: 20829367
J Clin Endocrinol Metab. 2014 Dec;99(12):E2762-71
pubmed: 25226293
J Clin Endocrinol Metab. 1998 Oct;83(10):3469-75
pubmed: 9768648
J Pediatr. 2006 Feb;148(2):234-40
pubmed: 16492435
J Clin Endocrinol Metab. 2014 Oct;99(10):3829-35
pubmed: 25029416
Breast Cancer Res. 2015 Nov 02;17(1):138
pubmed: 26526858
Trends Endocrinol Metab. 2015 Jul;26(7):376-83
pubmed: 26044465
PLoS One. 2015 Aug 06;10(8):e0134656
pubmed: 26247479
Pediatrics. 2007 Dec;120 Suppl 4:S164-92
pubmed: 18055651
Pediatr Res. 2020 Jul;88(1):117-124
pubmed: 31791040
Acta Paediatr. 2020 May;109(5):900-913
pubmed: 31730292
J Clin Endocrinol Metab. 2009 Jul;94(7):2594-601
pubmed: 19366843
Nat Rev Endocrinol. 2020 May;16(5):284-296
pubmed: 32203405
Lancet Oncol. 2009 Jun;10(6):569-80
pubmed: 19409844
Vital Health Stat 11. 2012 Oct;(252):1-48
pubmed: 25204692
Endocr Rev. 2003 Apr;24(2):152-82
pubmed: 12700178
Endocrinology. 2004 Jan;145(1):175-83
pubmed: 14512432
Pediatrics. 2013 Dec;132(6):1019-27
pubmed: 24190685
J Clin Endocrinol Metab. 2017 Mar 1;102(3):1001-1008
pubmed: 28009526
Ann N Y Acad Sci. 1990;595:199-211
pubmed: 2375604
J Endocrinol. 2004 Nov;183(2):331-42
pubmed: 15531721
Breast Cancer Res. 2002;4(4):155-64
pubmed: 12100741
J Clin Endocrinol Metab. 2019 Aug 1;104(8):3355-3361
pubmed: 30844044
Int J Obes (Lond). 2019 Oct;43(10):1978-1987
pubmed: 31462689
Am J Obstet Gynecol. 1970 Nov 1;108(5):833-46
pubmed: 5471242
J Clin Endocrinol Metab. 2009 Jan;94(1):56-66
pubmed: 18957503
J Clin Endocrinol Metab. 2013 Apr;98(4):1591-601
pubmed: 23457407
J Clin Endocrinol Metab. 2006 May;91(5):1714-22
pubmed: 16492701
J Clin Endocrinol Metab. 2009 Apr;94(4):1168-75
pubmed: 19190110
Clin Endocrinol (Oxf). 2007 Mar;66(3):440-6
pubmed: 17302881
Eur J Clin Nutr. 2018 Sep;72(9):1239-1245
pubmed: 30185840
Endocrinology. 2011 Oct;152(10):3728-37
pubmed: 21846805
Pediatr Obes. 2020 Dec;15(12):e12685
pubmed: 32614151
Ann Pediatr Endocrinol Metab. 2016 Dec;21(4):219-225
pubmed: 28164075
Pediatrics. 2008 Feb;121 Suppl 3:S172-91
pubmed: 18245511
Clin Endocrinol (Oxf). 2012 Oct;77(4):555-63
pubmed: 22443272
JAMA Pediatr. 2020 Apr 1;174(4):e195881
pubmed: 32040143
J Clin Endocrinol Metab. 2019 Oct 1;104(10):4390-4397
pubmed: 30985874
J Clin Endocrinol Metab. 1990 Apr;70(4):888-93
pubmed: 2318946
Transl Oncol. 2017 Dec;10(6):928-935
pubmed: 29024822
Cancer Res. 2010 Jan 15;70(2):741-51
pubmed: 20068149
Int J Obes (Lond). 2010 Sep;34(9):1415-26
pubmed: 20231845
Pediatrics. 1990 Dec;86(6):1001
pubmed: 2251014
J Pediatr Adolesc Gynecol. 2018 Aug;31(4):339-345
pubmed: 29758276
Pediatr Res. 2014 Dec;76(6):564-70
pubmed: 25192395
J Clin Endocrinol Metab. 2020 Dec 1;105(12):
pubmed: 32961560
Mediators Inflamm. 2016;2016:4549676
pubmed: 26884646
Pediatrics. 2009 May;123(5):e932-9
pubmed: 19403485
Lancet Neurol. 2016 Jan;15(1):56-64
pubmed: 26597325
Breast Cancer Res. 2009;11(5):212
pubmed: 19889198
Obesity (Silver Spring). 2010 Nov;18(11):2118-24
pubmed: 20339367
J Clin Endocrinol Metab. 1999 Oct;84(10):3666-72
pubmed: 10523012
Breast Cancer Res. 2020 May 11;22(1):44
pubmed: 32393308
J Clin Endocrinol Metab. 2017 Sep 1;102(9):3327-3339
pubmed: 28645211